Related Experiment Video

Updated: Jan 6, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.2K

Knockdown of GCNT2 promoted osteoblast differentiation by activating PI3K/AKT/mTOR pathway in osteoblasts

Yansheng Huang1, Sibo Wang1, Dong Hu2

  • 1Department of Spine Surgery, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710000, Shaanxi, China.

Scientific Reports
|November 26, 2025
PubMed

Insights

Glucosaminyl (N-acetyl) transferase 2 (GCNT2) gene knockdown promotes osteoblast differentiation in osteoporosis by activating the PI3K/AKT/mTOR pathway. This suggests GCNT2 inhibition as a potential therapeutic strategy for osteoporosis treatment.

Area of Science:

  • Bone Biology and Metabolism
  • Molecular Endocrinology
  • Biochemistry

Background:

  • Osteoporosis (OP) is a complex bone metabolic disorder with challenging pathogenesis.
  • Understanding the regulatory mechanisms of OP requires further investigation into gene expression.
  • Microarray profiling identified GCNT2 as a potentially significant gene in OP.

Purpose of the Study:

  • To investigate the role of Glucosaminyl (N-acetyl) transferase 2 (GCNT2) in osteoporosis.
  • To explore the therapeutic potential of targeting GCNT2 in OP.
  • To elucidate the molecular pathways involved in GCNT2-mediated osteoblast differentiation.

Main Methods:

  • Utilized microarray profiling to identify differentially expressed genes in OP patients.
  • Employed MC3T3-E1 osteoblasts as an in vitro model for OP, induced by dexamethasone (Dex).
  • Assessed osteoblast differentiation markers (ALP, ARS, Runx2, OCN, OPN) via qRT-PCR and Western blot analysis.

Main Results:

  • GCNT2 was found to be upregulated in OP patients and Dex-treated osteoblasts.
  • Knockdown of GCNT2 enhanced osteoblast differentiation markers and was linked to the PI3K/AKT/mTOR pathway.
  • Inhibition of PI3K with LY294002 attenuated the effects of GCNT2 knockdown, confirming pathway involvement.

Conclusions:

  • GCNT2 upregulation impairs osteoblast differentiation in an OP model.
  • Suppression of GCNT2 promotes osteoblast differentiation by activating the PI3K/AKT/mTOR signaling pathway.
  • GCNT2 knockdown shows promise as a potential therapeutic strategy for osteoporosis, warranting further pre-clinical evaluation.
Keywords:
GCNT2Osteoblast differentiationOsteoporosisPI3K/AKT/mTOR

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

8.3K
Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model08:42

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model

Published on: July 3, 2020

5.0K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
5.9K